BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12386934)

  • 1. Molecular control of lymphangiogenesis.
    Baldwin ME; Stacker SA; Achen MG
    Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular growth factors and lymphangiogenesis.
    Jussila L; Alitalo K
    Physiol Rev; 2002 Jul; 82(3):673-700. PubMed ID: 12087132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung.
    Greenberg JM; Thompson FY; Brooks SK; Shannon JM; McCormick-Shannon K; Cameron JE; Mallory BP; Akeson AL
    Dev Dyn; 2002 Jun; 224(2):144-53. PubMed ID: 12112468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the biology and pathology of the cutaneous lymphatic system.
    Hirakawa S; Detmar M
    J Dermatol Sci; 2004 Jun; 35(1):1-8. PubMed ID: 15194141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
    Dupuy E; Tobelem G
    Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa.
    Wittekindt C; Hess A; Bloch W; Sultanie S; Michel O
    Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):294-8. PubMed ID: 12115075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
    Mäkinen T; Jussila L; Veikkola T; Karpanen T; Kettunen MI; Pulkkanen KJ; Kauppinen R; Jackson DG; Kubo H; Nishikawa S; Ylä-Herttuala S; Alitalo K
    Nat Med; 2001 Feb; 7(2):199-205. PubMed ID: 11175851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the lymphatic vascular system: a mystery unravels.
    Hong YK; Shin JW; Detmar M
    Dev Dyn; 2004 Nov; 231(3):462-73. PubMed ID: 15376314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep.
    Petersen W; Unterhauser F; Pufe T; Zantop T; Südkamp NP; Weiler A
    Arch Orthop Trauma Surg; 2003 May; 123(4):168-74. PubMed ID: 12734715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
    McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
    J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS
    Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.